English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Novo Nordisk Inc.

Carol Ostrow | Nov 17, 2017

Diabetes 360 survey shows patient desire for more holistic care

Carol Ostrow | Nov 16, 2017

European study demonstrates economic benefits of Tresiba

Carrie Bradon | Sep 18, 2017

Novo Nordisk offers aid, collects donations for those affected by Harvey

Robert Hadley | Jun 20, 2017

Novo Nordisk’s Xultophy better for diabetics than insulin alone, study says

Cheyenne Dickerson | May 14, 2017

Obese adults begin to manage weight after life-changing medical event, study shows

Caitlin Nordahl | Apr 24, 2017

Novo Nordisk expands HemaGo for easy sharing of hemophilia treatment information

Ruth de Jauregui | Apr 14, 2017

FDA panel reviews license application for potential hemophilia B treatment

Gene Johnson | Mar 25, 2017

CVS Health to launch a new prescription savings program

Trending

+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program

+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’

+ Pharmaceuticals
Patient Daily | Jun 19, 2025

FDA loophole lets low-quality drugs from China and India flood U.S. market, while American manufacturers are held to higher standards

+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily